Search results
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 5 days agoA $4.9 billion hole has appeared in Gilead Sciences' pipeline. After years of setbacks, the Big Biotech dealt a final blow to its anti-CD47 monoclonal antibody< ...
Dengue Fever
Health via Yahoo News· 5 days agoBlood tests can be ordered to rule out other possible illnesses. There are two main types of blood tests used to diagnose dengue: antibody and molecular...
Drug appears to reverse type 1 diabetes in mice
Futurity· 18 hours agoAn experimental monoclonal antibody drug appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals’ lifespan ...
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 22 hours agoDelivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW. Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected ...
Dogs increasingly vulnerable to Lyme disease, tick-borne illnesses in early spring
Augusta Free Press· 7 days agoAn eight-legged arachnid the size of a poppy seed can cause major problems for your pets, and if...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 7 days agoModerna and Merck recently said they will test their cancer vaccine in addition to Keytruda in...
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
FOX 4 Kansas City· 6 days ago...ASCO) annual meeting, which will be held in Chicago, USA, from May 31-June 4, 2024. 9MW2821 is...
Taking the bite out of snake venom
Phys.org· 2 days agoEvery year around 5.4 million people globally—often in the world's poorest communities—are bitten by venomous snakes, with countries such as Bangladesh,...
Antigenic Characterization of Novel Human Norovirus GII.4 Variants San Francisco 2017 and Hong Kong...
Centers for Disease Control and Prevention· 5 days agoNovel Human Norovirus GII.4 Variants
OraSure Technologies (NASDAQ:OSUR) Rating Lowered to Hold at StockNews.com
ETF DAILY NEWS· 6 days agoOraSure Technologies (NASDAQ:OSUR – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Tuesday. Separately, ...
